• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利什曼病:中东地区近期的流行病学研究

Leishmaniasis: Recent epidemiological studies in the Middle East.

作者信息

Knight Chinyere A, Harris David R, Alshammari Shifaa O, Gugssa Ayele, Young Todd, Lee Clarence M

机构信息

Department of Biology, Tuskegee University, Tuskegee, AL, United States.

Department of Biology, University of Hafr Al-Batin, Hafr Al-Batin, Saudi Arabia.

出版信息

Front Microbiol. 2023 Feb 2;13:1052478. doi: 10.3389/fmicb.2022.1052478. eCollection 2022.

DOI:10.3389/fmicb.2022.1052478
PMID:36817103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9932337/
Abstract

Leishmaniasis, one of the most neglected tropical diseases (NTDs), is the third most important vector-borne disease worldwide. This disease has a global impact and severity of the infection and is greatest in the Middle East. The agent of infection is a protozoan parasite of the genus, , and is generally transmitted by blood-sucking female sandflies. In humans, there are three clinical forms of infection: (1) cutaneous (CL), (2) mucocutaneous (ML), and (3) visceral leishmaniasis (VL). This review aims to discuss the current epidemiological status of leishmaniasis in Saudi Arabia, Iraq, Syria, and Yemen with a consideration of treatment options. The elevated risk of leishmaniasis is influenced by the transmission of the disease across endemic countries into neighboring non-infected regions.

摘要

利什曼病是最被忽视的热带病之一,是全球第三重要的媒介传播疾病。这种疾病具有全球影响,感染的严重程度在中东地区最为严重。感染病原体是利什曼原虫属的原生动物寄生虫,通常由吸血雌性白蛉传播。在人类中,有三种临床感染形式:(1)皮肤型(CL),(2)黏膜皮肤型(ML),以及(3)内脏利什曼病(VL)。本综述旨在讨论沙特阿拉伯、伊拉克、叙利亚和也门利什曼病的当前流行病学状况,并考虑治疗选择。利什曼病风险的升高受到该疾病在流行国家向周边未感染地区传播的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9374/9932337/b810dc130fd1/fmicb-13-1052478-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9374/9932337/dbc3d78350a6/fmicb-13-1052478-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9374/9932337/9cbf4f04f4f6/fmicb-13-1052478-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9374/9932337/543b297726f4/fmicb-13-1052478-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9374/9932337/b810dc130fd1/fmicb-13-1052478-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9374/9932337/dbc3d78350a6/fmicb-13-1052478-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9374/9932337/9cbf4f04f4f6/fmicb-13-1052478-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9374/9932337/543b297726f4/fmicb-13-1052478-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9374/9932337/b810dc130fd1/fmicb-13-1052478-g004.jpg

相似文献

1
Leishmaniasis: Recent epidemiological studies in the Middle East.利什曼病:中东地区近期的流行病学研究
Front Microbiol. 2023 Feb 2;13:1052478. doi: 10.3389/fmicb.2022.1052478. eCollection 2022.
2
[Imported cutaneous leishmaniasis cases detected in truck drivers in Hatay].[在哈塔伊卡车司机中检测到的输入性皮肤利什曼病病例]
Mikrobiyol Bul. 2018 Jul;52(3):316-323. doi: 10.5578/mb.66937.
3
The leishmaniases in Kenya: A scoping review.肯尼亚的利什曼病:范围综述。
PLoS Negl Trop Dis. 2023 Jun 1;17(6):e0011358. doi: 10.1371/journal.pntd.0011358. eCollection 2023 Jun.
4
Status of vaccine research and development of vaccines for leishmaniasis.利什曼病疫苗的研发现状
Vaccine. 2016 Jun 3;34(26):2992-2995. doi: 10.1016/j.vaccine.2015.12.071. Epub 2016 Mar 11.
5
Neglected tropical diseases of the Middle East and North Africa: review of their prevalence, distribution, and opportunities for control.中东和北非的被忽视热带病:流行情况、分布及控制机会综述。
PLoS Negl Trop Dis. 2012;6(2):e1475. doi: 10.1371/journal.pntd.0001475. Epub 2012 Feb 28.
6
Clinical and epidemiological features of leishmaniasis in northwestern-Argentina through a retrospective analysis of recent cases.通过对近期病例的回顾性分析探讨阿根廷西北部利什曼病的临床和流行病学特征。
Acta Trop. 2016 Feb;154:125-32. doi: 10.1016/j.actatropica.2015.11.008. Epub 2015 Nov 21.
7
Leishmaniasis in the middle East: incidence and epidemiology.中东地区的利什曼病:发病率与流行病学
PLoS Negl Trop Dis. 2014 Oct 2;8(10):e3208. doi: 10.1371/journal.pntd.0003208. eCollection 2014 Oct.
8
The Geographical Distribution of Cutaneous Leishmaniasis Causative Agents in Iran and Its Neighboring Countries, A Review.伊朗及其邻国皮肤利什曼病病原体的地理分布:综述
Front Public Health. 2020 Feb 18;8:11. doi: 10.3389/fpubh.2020.00011. eCollection 2020.
9
Cutaneous Leishmaniasis in the Metropolitan City of Multan, Pakistan, a Neglected Tropical Disease.巴基斯坦木尔坦大都市的皮肤利什曼病,一种被忽视的热带疾病。
J Med Entomol. 2018 Jun 28;55(4):1040-1042. doi: 10.1093/jme/tjy003.
10
Vector and reservoir control for preventing leishmaniasis.通过病媒和宿主控制预防利什曼病
Cochrane Database Syst Rev. 2015 Aug 5;2015(8):CD008736. doi: 10.1002/14651858.CD008736.pub2.

引用本文的文献

1
A 12-year analysis of seasonal patterns and disease dynamics of in Saudi Arabia.沙特阿拉伯[疾病名称未给出]季节性模式和疾病动态的12年分析。
Saudi Med J. 2025 Aug;46(8):941-947. doi: 10.15537/smj.2025.46.8.20241124.
2
PubChem BioAssays 1063: A Poorly Exploited Source of New Antileishmanial Compounds.《公共化学数据库生物测定1063:新型抗利什曼原虫化合物的未充分利用来源》
J Parasitol Res. 2025 Jun 27;2025:6338486. doi: 10.1155/japr/6338486. eCollection 2025.
3
Commentary on the Issue of Infection: Focus on Some Pathogenetic, Clinical, and Epidemiological Aspects.

本文引用的文献

1
Impact of Modifiable Risk Factors on the Occurrence of Cutaneous Leishmaniasis in Diyala, Iraq: Case-Control Study.可改变的危险因素对伊拉克迪亚拉皮肤利什曼病发病的影响:病例对照研究
JMIRx Med. 2021 Jul 30;2(3):e28255. doi: 10.2196/28255.
2
Antileishmanial Activities of Medicinal Herbs and Phytochemicals In Vitro and In Vivo: An Update for the Years 2015 to 2021.抗利什曼原虫草药和植物化学物质的体外和体内抗利什曼原虫活性:2015 至 2021 年的更新。
Molecules. 2022 Nov 4;27(21):7579. doi: 10.3390/molecules27217579.
3
Visceral Leishmaniasis: Epidemiology, Diagnosis, and Treatment Regimens in Different Geographical Areas with a Focus on Pediatrics.
感染问题述评:聚焦一些发病机制、临床及流行病学方面
Vet Sci. 2025 Jun 1;12(6):536. doi: 10.3390/vetsci12060536.
4
Impact of COVID-19 on the incidence of visceral leishmaniasis in children and adolescents in the Northeast region, 2007-2022: time series study.2007 - 2022年新冠疫情对东北地区儿童和青少年内脏利什曼病发病率的影响:时间序列研究
Epidemiol Serv Saude. 2025 Jun 13;34:e20240382. doi: 10.1590/S2237-96222025v34e20240382.en. eCollection 2025.
5
Epidemiological investigation and diagnostic comparison of cutaneous leishmaniasis in Kalaleh city, Iran: a parasitological and molecular approach.伊朗卡拉莱赫市皮肤利什曼病的流行病学调查与诊断比较:寄生虫学和分子方法
J Parasit Dis. 2025 Jun;49(2):351-358. doi: 10.1007/s12639-024-01753-4. Epub 2024 Nov 7.
6
Erysipeloid leishmaniasis, a rare case of atypical cutaneous leishmaniasis misdiagnosed initially as rosacea.类丹毒样利什曼病,一种罕见的非典型皮肤利什曼病病例,最初被误诊为酒渣鼻。
JAAD Case Rep. 2025 Apr 4;60:15-18. doi: 10.1016/j.jdcr.2025.01.048. eCollection 2025 Jun.
7
Recent Progress in Thiazole, Thiosemicarbazone, and Semicarbazone Derivatives as Antiparasitic Agents Against Trypanosomatids and spp.噻唑、缩氨基硫脲和氨基脲衍生物作为抗锥虫和其他物种抗寄生虫剂的最新进展
Molecules. 2025 Apr 16;30(8):1788. doi: 10.3390/molecules30081788.
8
Improving reproducibility and translational potential of mouse models: lessons from studying leishmaniasis.提高小鼠模型的可重复性和转化潜力:利什曼病研究的经验教训。
Front Immunol. 2025 Apr 22;16:1559907. doi: 10.3389/fimmu.2025.1559907. eCollection 2025.
9
Lesionia: a digital data management system to enhance collaborative management of epidemiological and clinical data of cutaneous leishmaniases patients.Lesionia:一个用于加强皮肤利什曼病患者流行病学和临床数据协作管理的数字数据管理系统。
BMC Res Notes. 2025 Apr 11;18(1):160. doi: 10.1186/s13104-025-07208-0.
10
Essential Oil Extract: Potential Antileishmanial Activity Induced by an Apoptotic-like Death.精油提取物:类凋亡性死亡诱导的潜在抗利什曼原虫活性。
Antibiotics (Basel). 2025 Mar 12;14(3):293. doi: 10.3390/antibiotics14030293.
内脏利什曼病:不同地理区域的流行病学、诊断及治疗方案,重点关注儿科
Microorganisms. 2022 Sep 21;10(10):1887. doi: 10.3390/microorganisms10101887.
4
Pilot study of safety and efficacy of topical liposomal amphotericin B for cutaneous leishmaniasis caused by Leishmania major in Islamic Republic of Iran.伊朗伊斯兰共和国局部应用脂质体两性霉素B治疗硕大利什曼原虫引起的皮肤利什曼病的安全性和有效性的初步研究。
East Mediterr Health J. 2022 Sep 29;28(9):658-663. doi: 10.26719/emhj.22.070.
5
Review of the neglected tropical diseases programme implementation during 2012-2019 in the WHO-Eastern Mediterranean Region.2012-2019 年世卫组织东地中海区域被忽视热带病规划实施情况审查。
PLoS Negl Trop Dis. 2022 Sep 29;16(9):e0010665. doi: 10.1371/journal.pntd.0010665. eCollection 2022 Sep.
6
Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial.巴龙霉素和米替福新联合治疗东非内脏利什曼病患者的疗效:一项随机对照多中心临床试验。
Clin Infect Dis. 2023 Feb 8;76(3):e1177-e1185. doi: 10.1093/cid/ciac643.
7
An overview of the functionalities of PubMed.PubMed的功能概述。
J R Coll Physicians Edinb. 2022 Mar;52(1):8-9. doi: 10.1177/14782715221088906.
8
Cutaneous Leishmaniasis: A 2022 Updated Narrative Review into Diagnosis and Management Developments.皮肤利什曼病:2022 年更新的诊断和治疗进展叙述性综述。
Am J Clin Dermatol. 2022 Nov;23(6):823-840. doi: 10.1007/s40257-022-00726-8. Epub 2022 Sep 14.
9
Research progress of health care in Yemeni children during the war: review.也门儿童在战争期间的医疗保健研究进展:综述。
Prim Health Care Res Dev. 2022 Sep 12;23:e55. doi: 10.1017/S1463423622000421.
10
Identification of protein biomarkers of attenuation and immunogenicity of centrin or p27 gene deleted live vaccine candidates of Leishmania against visceral leishmaniasis.鉴定 centrin 或 p27 基因缺失的利什曼原虫活疫苗候选物对内脏利什曼病的减毒和免疫原性的蛋白质生物标志物。
Parasitol Int. 2023 Feb;92:102661. doi: 10.1016/j.parint.2022.102661. Epub 2022 Aug 29.